Appili Therapeutics to delist from TSX on Oct. 2, transfer to NEX Oct. 5

PUBT · 2d ago
Appili Therapeutics to delist from TSX on Oct. 2, transfer to NEX Oct. 5
  • Appili Therapeutics will delist its Class A common shares from the TSX on Oct. 2, 2026.
  • Move follows failure to meet TSX continued listing requirements.
  • Shares set to begin trading on the NEX Board of the TSX Venture Exchange on Oct. 5, 2026.
  • Ticker will change to APLI.H from APLI; no change to name or CUSIP, no share consolidation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Appili Therapeutics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609290830NEWSFILECNPR____20260929_316490_1) on September 29, 2026, and is solely responsible for the information contained therein.